On March 31, 2026, Garmin and Natural Cycles announced a product integration that turns five Garmin smartwatch models into FDA-cleared non-hormonal birth control devices. Users wear a compatible Garmin watch overnight — the fenix 8, Forerunner 570, Forerunner 970, Venu 4, or Venu X1 — and their skin temperature data automatically syncs to the Natural Cycles app each morning to determine daily fertility status with a simple green (not fertile) or red (fertile/use protection) indicator.

Why It Matters

This is arguably the most significant femtech distribution play of 2026. By piggybacking on Garmin's enormous hardware install base, Natural Cycles bypasses the cold-start problem that plagues standalone fertility wearables — women don't need to buy a new device, they just enable an app integration on a watch they already wear. The move also positions fertility tracking as a standard smartwatch feature rather than a niche women's health add-on, which could accelerate mainstream adoption and destigmatize digital contraception. For the broader sex tech industry, the Garmin partnership validates the "health platform" positioning that companies like Elvie, Clue, and Flo have been pursuing — the winning strategy may not be building hardware but building the algorithm layer that runs on existing devices.

The integration leverages Natural Cycles' existing FDA clearance as a digital contraceptive, extending it from the company's own NC Band wearable ($129.99, launched January 2026) to Garmin's massive install base of fitness-focused consumers. This is the first time an FDA-cleared birth control algorithm has been paired with a mainstream fitness smartwatch brand, significantly lowering the barrier to entry for women who already wear a Garmin but wouldn't purchase a dedicated fertility device.

The partnership is available across nine markets — the U.S., UK, EU, Australia, Brazil, Canada, Norway, Singapore, and Switzerland — reflecting Natural Cycles' global regulatory clearances. Susan Lyman, Garmin's VP of Consumer Sales, stated: "Women all over the world utilize Garmin products for activity and health tracking, which is why this integration with Natural Cycles is so important." Dr. Elina Berglund Scherwitzl, Natural Cycles co-founder and CEO, called Garmin "a natural next step as we expand our wearable ecosystem."

Natural Cycles, which has over 5 million registered users, previously launched the NC Band wearable and the NC Perimenopause algorithm mode — the first app mode powered by its own dedicated algorithm that estimates perimenopause stages. The Garmin integration represents the company's shift from proprietary hardware toward a platform strategy where the algorithm runs on whatever wearable users already own.

Sources

Update — 2026-04-08

Initial entry — story first created.

Update — 2026-08-05

Natural Cycles added its biggest wearable partner yet. On August 4, 2026, WHOOP announced it has integrated with Natural Cycles, using overnight skin temperature from WHOOP's MG and 5.0 devices to power the NC° app's fertility and hormone-free birth control insights — and it's bundling a free 12-month NC° subscription for eligible WHOOP members new to Natural Cycles. As with Garmin, the integration auto-syncs overnight skin temperature, removing manual measurement and letting users track fertile/non-fertile days plus fertility, pregnancy, postpartum, and perimenopause insights.

The deal underscores the platform-not-hardware thesis: Natural Cycles now runs on Oura, Garmin, Apple Watch, and its own NC° Band, and adds WHOOP's fast-growing female base (WHOOP says its female membership grew 111% year over year). WHOOP CMO Dr. Ami Bhatt framed it as "supporting women's health through clinically-backed, actionable data" and expanding WHOOP "beyond performance into everyday health." Natural Cycles VP of Product Dr. Magda Armbruster said the integration "removes friction" by letting members use "the wearable they already rely on." The free-year subscription is a notable customer-acquisition lever — WHOOP essentially subsidizing NC°'s funnel into a health-motivated audience.

New Sources